Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03606239
What this trial is testing

NSCLC Isotoxic Hypofractionated Chemoradiotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
The Second Hospital of Hebei Medical University 30
Testing effectiveness (Phase 2)Study completedNCT01497873
What this trial is testing

Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Chong Kun Dang Pharmaceutical 164
Testing effectiveness (Phase 2)Ended earlyNCT00830245
What this trial is testing

Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer

Who this might be right for
Leptomeningeal CarcinomatosisNon-small Cell Lung Cancer
Clinical Research Center for Solid Tumor, Korea 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06780839
What this trial is testing

Adjuvant Treatment of ALK-positive Non-small Cell Lung Cancer with Ensartinib Guided by MRD

Who this might be right for
NSCLC, Stage I, II, IIIA, IIIB
Peking University Cancer Hospital & Institute 70
Not applicableLooking for participantsNCT05456841
What this trial is testing

Empathic Communication Skills (ECS) Training

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 1,232
Large-scale testing (Phase 3)Not Yet RecruitingNCT07718737
What this trial is testing

Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Multitude Therapeutics Inc. 512
Early research (Phase 1)Ended earlyNCT04800822
What this trial is testing

PF-07284892 in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Pfizer 53
Testing effectiveness (Phase 2)Looking for participantsNCT07174583
What this trial is testing

IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Who this might be right for
Small-cell Lung CancerNeuroendocrine CarcinomasSolid Tumor Show to Express DLL3
IDEAYA Biosciences 262
Not applicableLooking for participantsNCT06304441
What this trial is testing

Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer

Who this might be right for
Leptomeningeal Metastasis
Guangzhou Medical University 100
Not applicableEnded earlyNCT05609331
What this trial is testing

Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 3
Early research (Phase 1)Ended earlyNCT06376253
What this trial is testing

A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers

Who this might be right for
Ovarian CancerLung Cancer
Novartis Pharmaceuticals 4
Very early researchLooking for participantsNCT06712745
What this trial is testing

Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung

Who this might be right for
Cancer, LungMetastasis
University of Texas Southwestern Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971501
What this trial is testing

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00238251
What this trial is testing

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

Who this might be right for
Lung CancerMetastatic Cancer
Swiss Cancer Institute 59
Early research (Phase 1)WithdrawnNCT05039931
What this trial is testing

GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Large-scale testing (Phase 3)UnknownNCT01407822
What this trial is testing

Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 72
Testing effectiveness (Phase 2)UnknownNCT03754530
What this trial is testing

Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases
Betta Pharmaceuticals Co., Ltd. 162
Early research (Phase 1)Ended earlyNCT04209465
What this trial is testing

BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.

Who this might be right for
Solid Tumor
Black Diamond Therapeutics, Inc. 91
Early research (Phase 1)Active Not RecruitingNCT05557045
What this trial is testing

JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

Who this might be right for
Advanced CancerMetastatic CancerSolid Tumor+4 more
Jazz Pharmaceuticals 98
Not applicableStudy completedNCT06557967
What this trial is testing

Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment

Who this might be right for
Non-small Cell Lung CancerLung CancerMetastatic Cancer+1 more
Daiichi Sankyo 22,517
Next Page